Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesJD Health International Inc

JD Health International Inc

Healthcare Pharmaceutical Retailers
PortfolioPortfolio WatchlistWatchlist
Company price
4.79 USD 0.00(0%)
Last update at 2026-11-05T21:00:00Z
VOLUME
100
Market Cap
13954.20M
P/E
15.09

Momentum Score

…

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
4.79
Low
4.79
High
52 Week Price Range
4.38
Low
8.75
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

JD Health International Inc operates digital healthcare and e‑pharmacy platforms in China, providing telemedicine, online prescription fulfillment and health-management services. Long-term growth may be supported by China’s aging population, rising digital-health adoption and access to JD.com’s logistics and customer base, which could appeal to investors seeking exposure to healthcare technology.
Key risks include regulatory and policy changes for online medical services and data privacy, strong competition in digital health and pharmacy, reliance on the JD.com ecosystem, and execution risk in achieving sustained profitability and compliance.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
4.79
Dividend Yield
-
Revenue TTM
79039.32M
Revenue Per Share
24.92
Gross Profit TTM
19993.24M
Debt / Equity
0.01
ROE
10.40%
Net Debt
-31172.13M
ROCE
6.08%
Diluted EPS TTM
0.29

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 5874.39M 4796.68M 2693.35M 695.81M -901.49M
Minority interest 8.30M 4.83M -1.04M -3.12M -0.69M
Net income 5236.69M 4161.84M 2141.84M 380.11M -1073.51M
Selling general administrative 1162.66M 1419.04M 1998.38M 2153.53M 5536.22M
Selling and marketing expenses 3842.62M 3048.73M 2654.97M 2195.76M 2133.84M
Gross profit 17729.52M 13308.58M 11865.34M 9891.51M 7197.28M
Reconciled depreciation 279.99M 214.69M 227.46M 140.68M 63.17M
Ebit 3699.99M 4804.87M 630.85M 803.11M -857.14M
Ebitda 3972.75M 5019.56M 858.31M 943.79M -793.97M
Depreciation and amortization 272.76M 214.69M 227.46M 140.68M 63.17M
Operating income 3699.99M 1478.76M 630.85M 803.11M -857.14M
Other operating expenses 67846.28M 56681.12M 52899.09M 46783.07M 32047.96M
Interest expense 10.81M 8.19M 9.48M 9.10M 6.00M
Tax provision 662.89M 639.66M 550.47M 312.58M 171.33M
Interest income 1537.53M 1960.50M 1949.03M 864.27M 457.57M
Net interest income 1526.44M 1952.31M 1939.55M 855.17M 451.57M
Income tax expense 645.78M 639.66M 550.47M 312.58M 171.33M
Total revenue 71546.27M 58159.88M 53529.94M 46736.15M 30682.27M
Total operating expenses 14029.53M 11829.81M 11234.49M 9938.43M 8562.98M
Cost of revenue 53816.75M 44851.30M 41664.61M 36844.64M 23484.99M
Total other income expense net 2174.40M 3317.91M 2062.50M -107.30M -44.35M
Net income from continuing ops 5367.11M 4157.01M 2142.88M 383.23M -1072.82M
Net income applicable to common shares - - - - -1073.51M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 81627.81M 71274.99M 64288.30M 61277.30M 48002.22M
Intangible assets 1933.22M 2094.53M 2182.20M - -
Other current assets 499.13M 822.50M 837.30M 757.41M 8.61M
Total liab 21524.26M 16034.16M 14918.04M 16492.73M 8147.63M
Total stockholder equity 60102.17M 55231.16M 49355.75M 44780.25M 39853.39M
Other current liab 6776.44M 4739.98M 4491.68M 5759.48M 2452.41M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings -7975.31M -13224.14M -17336.03M -19382.06M -19714.84M
Other liab - - - - 8.89M
Other assets - - - 787.45M 979.65M
Cash 31808.47M 22628.87M 15037.03M 18717.72M 17252.29M
Total current liabilities 20751.89M 15521.02M 14585.00M 16356.15M 8005.03M
Current deferred revenue 552.59M - 781.23M - -
Net debt -31172.13M -22370.48M -14822.28M -18518.31M -17051.03M
Short term debt 206.64M 109.67M 95.32M 70.65M 67.55M
Short long term debt total 636.34M 258.39M 214.75M 199.41M 201.27M
Other stockholder equity 61388.65M 59916.51M 66691.77M 64162.30M 59568.22M
Property plant equipment - - - - 260.77M
Total current assets 56377.20M 58460.42M 47849.89M 56447.16M 45705.48M
Net tangible assets - - - - 39828.00M
Short term investments 16365.83M 28606.81M 26184.23M 28248.49M 24737.78M
Net receivables 436.52M 559.57M 718.96M 2727.27M 665.54M
Inventory 7291.05M 5842.66M 5084.57M 5996.27M 3041.24M
Accounts payable 13216.22M 10423.31M 9660.45M 10526.03M 5485.07M
Accumulated other comprehensive income 6657.78M 8538.77M 8233.08M - -
Non currrent assets other 31.44M 35639.03M 771.59M 28727.07M 25473.60M
Non current assets total 25250.61M 12814.58M 16438.41M 4830.14M 2296.74M
Capital lease obligations 636.02M 258.39M 214.75M 199.41M 201.27M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -464.56M 3146.44M -8022.89M -4235.54M -17247.24M
Change to liabilities - - - 6020.50M 2801.42M
Total cashflows from investing activities -575.41M 3146.44M -8022.89M - -17752.15M
Net borrowings - - - -47.56M -32.33M
Total cash from financing activities -77.11M -45.61M -117.20M -925.45M -163.65M
Change to operating activities - - - 665.08M 843.36M
Net income 5367.11M 4157.01M 2141.84M 383.23M -1072.82M
Change in cash 10108.10M 7591.84M -3680.69M 1465.43M -15018.50M
Begin period cash flow 21700.37M 15037.03M 18717.72M 17252.29M 32270.79M
End period cash flow 31808.47M 22628.87M 15037.03M 18717.72M 17252.29M
Total cash from operating activities 9936.78M 4332.37M 4604.78M 5905.15M 3430.72M
Issuance of capital stock - - - - 0.00M
Depreciation 279.99M 214.69M 227.46M 140.68M 63.17M
Other cashflows from investing activities 58.80M -17.28M 17.62M -5.41M 5.18M
Change to inventory -998.39M -523.37M 791.61M -3151.38M -1286.16M
Change to account receivables -27.00M -212.71M 537.14M -685.08M -331.40M
Sale purchase of stock - 0.00M -69.10M -869.03M -126.41M
Other cashflows from financing activities -77.11M -8.19M -48.10M -56.41M -37.25M
Change to netincome - - - 2535.23M 2413.84M
Capital expenditures 151.01M 46.35M 69.33M 2272.95M 518.16M
Change in working capital 3507.10M 524.74M 214.38M 2849.14M 2027.21M
Stock based compensation 590.72M 1129.60M 1847.79M 2104.28M 2579.71M
Other non cash items 191.86M -1693.68M 173.31M -844.98M -495.94M
Free cash flow 10022.94M 4286.01M 4535.44M 3632.20M 2912.56M

Peer Comparison*

Sector: Healthcare Industry: Pharmaceutical Retailers

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
JDHIF
JD Health International Inc		 -
-%		 4.79 15.09 15.11 0.18 1.52 0.59 6.26
ALBBY
Alibaba Health Information Technology Limited		 -
-%		 7.65 34.43 19.84 0.29 3.79 1.73 25.72
RADLY
Raia Drogasil SA ADR		 0.09
3.35%		 2.78 22.35 24.69 0.14 4.59 0.90 10.93
ALBHF
Alibaba Health Information Technology Limited		 -
-%		 0.33 17.35 16.69 0.16 2.11 0.89 13.04
RTEZ
Rest EZ Inc.		 -
-%		 70.00 - - 385518.44 5.92 - -

Profile*

JD Health International Inc

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

Jingdong Headquarters, Beijing, China, 101111

https://ir.jdhealth.com

6018

Name Title Year Born
Mr. Enlin Jin CEO & Exec. Director 1981
Mr. Dong Cao Chief Financial Officer NA
Mr. Cao Dong CEO & Director 1977
Ms. Deng Hui Chief Financial Officer 1987
Mr. Ming King Chiu FCIS, FCS Company Secretary 1977

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…